Herrera AJ, Castao A, Venero JL, Cano J, Machado A
In a US supervised clinical setting it is prescribed by a licensed provider, compounded by a licensed pharmacy, and used for specific longevity goals under documented follow-up
5.5 Cell therapy for targeting the TME Modulating the microenvironment via cell therapy has been successfully performed to treat other non-cancer related injuries, in ways that could be translatable to treating the damaged microenvironment post-cancer treatment and/or to aid with the regeneration process following such damage
Results are informational and research-use only
Musculoskeletal Research: Studied in tendon, ligament, and muscle injury models, where it has been linked with improved angiogenesis and repair responses
The clinical preference for transdermal delivery